29 November 2024
One Health Group
PLC
('One
Health' or the 'Group')
Update on Timing of Half Year
Results
One Health (AQSE: OHGR), an
independent provider of free, high quality NHS care for patients
referred through 'Patient Choice' for treatment in orthopaedics,
spine, general surgery and gynaecology, will announce its Half Year
Results for the six months ended 30 September 2024 during
December.
This timing update for the release
of the Group's half year results reflects the Group's adoption of
International Financial Reporting Standards ("IFRS") for the first
time in consideration of a potential move to AIM in 2025.
Previously, the Group has reported its results under United Kingdom
Generally Accepted Accounting Principles (UK GAAP).
The directors of One Health accept
responsibility for this announcement.
- Ends -
For further
enquiries:
One Health
Group PLC
|
Via Square One
Consulting
|
Derek Bickerstaff, Chairman
|
|
Adam Binns, CEO
|
|
|
|
|
|
Panmure
Liberum
Emma Earl, Will Goode, Mark Rogers, Joshua
Borlant,
Rupert Dearden
|
Tel: +44 (0) 20 3100
2000
|
|
|
Square 1
Consulting Limited
|
|
David Bick
|
Tel: +44 (0) 207929
5599
+44 (0) 7831 381201
|
|
|
Notes to
Editors
One Health engages over 100 NHS Consultants who
sub-specialise in the various surgeries offered by the Company,
through a growing network of community-based outreach clinics and
surgical operating locations. One Health continues to deliver
strong growth and in the year to March 2024 provided much needed
care to 13,266 new patients, through almost 34,000 consultations
and over 6,000 surgical procedures. One Health deploys surgeons and
anaesthetists that are mostly employed by the NHS, on a
subcontracted basis. It currently works with over 100 professionals
across 9 independent hospitals and 37 CQC registered outreach
clinics. Within these community-based outreach clinics all
consultations and post operative physiotherapy is delivered where
required, reducing patient inconvenience and excess
travel.
One Health's activities are focused on areas
where NHS patient needs are under-supplied by the local NHS
service, population density is relatively high and the level of
private medical insurance or the ability to self-fund is relatively
low. One Health has also sought to expand geographically from its
Head Office in Sheffield into neighbouring counties, which meet
these criteria. Currently, the Company's activities are focused in
Yorkshire, Lincolnshire, Derbyshire, Nottinghamshire and
Leicestershire. Revenue of over £23m in the year to 31 March 2024
was derived from over 60 NHS commissioning bodies in addition to
contracts with local NHS Hospital Trusts to transfer their internal
waiting list patients to One Health for quicker
treatment.
One Health's business model has focused to date
on four main areas: being Orthopaedics, Spine, General Surgery and
Gynaecology. The split of inpatient procedures in the year to 31
March 2024 was as follows: Orthopaedics 46% Spine 22% General
Surgery 22% Gynaecology 10%.
Spine and orthopaedics are particularly
attractive areas for One Health as the Directors believe that they
benefit from powerful growth drivers in terms of an ageing
demographic, physical inactivity and an increasing proportion of
the population being categorised as obese. Within orthopaedics, the
most common surgeries performed by One Health are knee and hip
replacements.
One Health delivered 6,169 procedures in the
year to 31 March 2024 and the Directors expect the Company to
deliver significantly more procedures in the year to 31 March
2025.
One Health was admitted to trading on Aquis in
November 2022 with the ticker OHGR.AQ.
For additional information please visit
https://www.aquis.eu/companies/OHGR
One Health was admitted to trading on Aquis in
November 2022 with the ticker OHGR.AQ. For additional
information please visit https://www.aquis.eu/companies/OHGR